Preclinical Pharmacokinetics, Biodistribution, and Acute Toxicity Evaluation of Caerin 1.9 Peptide in Sprague Dawley Rats

Figure 2

The concentration-time profiles of F3 after a single dose (10.0 mg/kg) and after repeated daily dosing with 10.0 mg/kg of F3 for 14 days. (a) The concentration-time profiles in plasma following subcutaneous injection of F3 at 1.0 mg/kg once. (b) The concentration-time profiles after a single dose (10.0 mg/kg) and repeated daily dosing with 10.0 mg/kg of F3 for 14 days.